Sponsor Products: ARROW® PICC with Chlorag+ard® Technology
Description of the Product
ARROW® PICC with Chlorag+ard® Technology is the world's first pressure injectable PICC that offers both antimicrobial and antithrombogenic protection for at least 30 days. The application of Chlorag+ard® Technology uses a proprietary process whereby chlorhexidine is chemically bonded to the intra- and extra-luminal catheter surfaces from tip to hub.
How It Works
Chlorag+ard® Technology is proven to provide 99.99% colonization reduction against gram-positive, gram-negative and fungi that are most often associated with catheter-related bloodstream infections.17
Additionally, Chlorag+ard® Technology provides antithrombogenic protection due to thrombin inhibition by chlorhexidine. Inhibition of thrombin does not allow the final step of the common pathway of blood coagulation - the conversion of soluble fibrinogen to fibrin clot. The ARROW® PICC with Chlorag+ard® Technology has demonstrated:
- 61% reduction in thrombus accumulation on catheter surfaces after 30 days as compared to control catheters, in vivo intravascular study17
- 92% reduction in thrombus accumulation on catheter surfaces in the presence of infection after 30 days as compared to control catheters, in vivo intravascular study17
- 51% less pressure to clear thrombus evidencing a reduced thrombotic intraluminal occlusion as compared to control catheters, in vivo intravascular study17
- 72% less intimal hyperplasia on average and a reduction in phlebitis after 30 days as compared to control catheters, in vivo intravascular study17
For more information, please visit www.chloragard.com.
Arrow and Chlorag+ard are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.